Correction to: Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.
作者信息
Yan Shibai, Fang Juntao, Chen Yongcai, Xie Yong, Zhang Siyou, Zhu Xiaohui, Fang Feng
机构信息
Department of Medical Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
Laboratory of Experimental Cardiology, Department of Cardiology, University Medical Center Utrecht, Utrecht, 3584, CX, The Netherlands.
出版信息
BMC Cancer. 2021 Jan 12;21(1):55. doi: 10.1186/s12885-020-07724-1.
Abstract
摘要
相似文献
1
Correction to: Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.对《基于卵巢癌免疫浸润的预后基因特征综合分析》的更正
BMC Cancer. 2021 Jan 12;21(1):55. doi: 10.1186/s12885-020-07724-1.
2
Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer.构建整合 miRNA 和 mRNA 免疫细胞特征，以预测乳腺癌和卵巢癌患者的生存。
Genes Chromosomes Cancer. 2019 Jan;58(1):34-42. doi: 10.1002/gcc.22688. Epub 2018 Nov 18.
3
Prognostic immune-related gene models for breast cancer: a pooled analysis.乳腺癌的预后免疫相关基因模型：一项汇总分析。
Onco Targets Ther. 2017 Sep 11;10:4423-4433. doi: 10.2147/OTT.S144015. eCollection 2017.
4
RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.泛癌分析中的RNA免疫特征对高级别浆液性卵巢癌和其他女性癌症具有预后价值。
Cancers (Basel). 2020 Mar 7;12(3):620. doi: 10.3390/cancers12030620.
5
Two microRNA signatures for malignancy and immune infiltration predict overall survival in advanced epithelial ovarian cancer.用于预测晚期上皮性卵巢癌总生存期的两种恶性肿瘤和免疫浸润的微小RNA特征
J Investig Med. 2017 Oct;65(7):1068-1076. doi: 10.1136/jim-2017-000457. Epub 2017 Jul 17.
6
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors.免疫激活的基因组特征可预测晚期卵巢癌和基底样乳腺癌的预后。
Front Oncol. 2020 Jan 10;9:1486. doi: 10.3389/fonc.2019.01486. eCollection 2019.
7
Conservation of immune gene signatures in solid tumors and prognostic implications.实体瘤中免疫基因特征的保守性及其预后意义。
BMC Cancer. 2016 Nov 22;16(1):911. doi: 10.1186/s12885-016-2948-z.
8
Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.肿瘤相关B细胞和浆细胞在上皮性卵巢癌中的预后影响
J Ovarian Res. 2016 Apr 6;9:21. doi: 10.1186/s13048-016-0232-0.
9
Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies.基于生物标志物的肺癌临床研究中已发表基因表达预后特征的综合评估。
Ann Oncol. 2017 Apr 1;28(4):733-740. doi: 10.1093/annonc/mdw683.
10
Novel Model for Comprehensive Assessment of Robust Prognostic Gene Signature in Ovarian Cancer Across Different Independent Datasets.跨不同独立数据集全面评估卵巢癌稳健预后基因特征的新模型
Front Genet. 2019 Oct 11;10:931. doi: 10.3389/fgene.2019.00931. eCollection 2019.
引用本文的文献
1
Considering Computational Mathematics IGHG3 as Malignant Melanoma Is Associated with Immune Infiltration of Malignant Melanoma.考虑将计算数学中的IGHG3 视为恶性黑色素瘤与恶性黑色素瘤的免疫浸润有关。
Biomed Res Int. 2022 Apr 18;2022:4168937. doi: 10.1155/2022/4168937. eCollection 2022.
本文引用的文献
1
Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.基于卵巢癌免疫浸润的预后基因特征综合分析。
BMC Cancer. 2020 Dec 7;20(1):1205. doi: 10.1186/s12885-020-07695-3.
Zotero 插件